Provided by Tiger Fintech (Singapore) Pte. Ltd.

Home Depot

362.75
+3.370.94%
Post-market: 354.11-8.6400-2.38%16:53 EDT
Volume:2.66M
Turnover:961.85M
Market Cap:360.55B
PE:24.33
High:363.78
Open:360.48
Low:359.76
Close:359.38
Loading ...

Big Box Retailers Hit by Increases in China, Vietnam Tariffs -- Market Talk

Dow Jones
·
04 Apr

Clear Secure Stock Rises 11% in a Month: Is it a Good Time to Invest?

Zacks
·
03 Apr

Retailers Were Hit Hard on Trump Tariffs

Tiger Newspress
·
03 Apr

RH's Q4 Earnings & Revenues Lag Estimates, Up Y/Y, Stock Down 26%

Zacks
·
03 Apr

AFC HD AMS Life Science Sees 1H Parent Pretax Y1.37B

Dow Jones
·
03 Apr

Consumer Stocks Have Taken a Beating. These 5 Could Shine

Dow Jones
·
03 Apr

24H|Mega-Cap Growth Stocks Fell With Apple Down 6%; Semiconductor, Crypto and Retail Stocks Tumbled with MU, MARA and WMT down 6%

Tiger Newspress
·
03 Apr

Dow's 250-Point Rally Highlighted By Gains For Goldman Sachs, Amazon.Com Inc. Shares

Dow Jones
·
03 Apr

Is DoorDash's Expanding Partner Base a Sign to Buy the Stock?

Zacks
·
03 Apr

Square Enix Announces Final Fantasy VII Remake Intergrade and Bravely Default Flying Fairy HD Remaster Are Coming to Nintendo Switch™ 2

Business Wire
·
02 Apr

Retailers Are Dreading Tariffs. 8 Companies That Could Weather the Storm. -- Barrons.com

Dow Jones
·
02 Apr

Home Depot Stock Slips Below Key SMAs: Value Play or Warning Sign?

Zacks
·
02 Apr

Trump's 'Liberation Day' tariffs may send prices for these 3 common household products higher

Yahoo Finance
·
02 Apr

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
02 Apr

UBS Unveils Top 30 Stock Picks Across All S&P Sectors

GuruFocus.com
·
01 Apr

Walmart, Sherwin-Williams Co. Share Gains Lead Dow's 367-Point Jump

Dow Jones
·
01 Apr

US STOCKS-S&P 500, Nasdaq slip as investors await major tariff news

Reuters
·
01 Apr

Dow's 260-Point Rally Led By Gains For Walmart, Home Depot Stocks

Dow Jones
·
01 Apr

3 Dow Jones Stocks in the Doghouse

StockStory
·
31 Mar

Neurocrine Biosciences Presents Real-World Data on Therapeutic Dose Attainment and Dosing Trends of VMAT2 Inhibitors in Patients With Tardive Dyskinesia

PR Newswire
·
31 Mar